A quick peek into the report
Table of Contents
1.1 | Scope of the Report |
1.2 | Global Computer Aided Diagnostics Market Segmentation |
1.3 | Key Learnings |
1.4 | Research Methodology |
1.4.1 | Data Triangulation |
1.4.2 | Key Data Points From Secondary Sources |
1.4.3 | Key Data Points From Primary Sources |
1.4.4 | Top-Down Approach (Segmental Analysis) |
1.4.5 | Bottom-Up Approach (Segmental Analysis) |
1.4.6 | Assumption and Limitations |
1.4.7 | Data and Prediction Modelling |
2.1 | Introduction |
2.2 | Market Trend |
2.3 | Evaluation method for CAD |
2.4 | Involvement of Deep Learning in CADx |
2.5 | CADx Deep Learning need in Radiology |
2.6 | Advantages of Computer Aided Diagnostics |
2.7 | Some Restraining Factors in Widespread Adoption of CADx Deep Learning Algorithm |
2.8 | CADx-Recent Developments |
3.1 | Overview |
3.2 | Market Drivers |
3.3 | Market Restraints |
3.4 | Market Challenges |
3.5 | Market Opportunities |
4.1 | Key Market Development Snapshot |
4.1.1 | New Product Launches, Developments and Testing |
4.1.2 | Patents, Approvals and Certifications |
4.1.3 | Mergers and Acquisitions |
4.1.4 | Collaborations, Joint Ventures & Partnerships |
4.1.4 | Business Expansion |
4.1.5 | Others Strategies |
4.2 | Technological Trend |
4.3 | Legal Requirements and Regulations |
4.4 | Supply Chain Analysis |
5.1 | Patent Landscape |
5.2 | Consortiums, Associations and Regulatory Bodies |
6.1 | Overview |
6.2 | Oncology |
6.2.1 | Breast Cancer |
6.2.2 | Lung Cancer |
6.2.3 | Colorectal Cancer |
6.2.4 | Prostate Cancer |
6.2.5 | Liver Cancer |
6.2.6 | Other Cancers |
6.2 | Other Diseases |
7.1 | Overview |
7.2 | Mammography |
7.3 | Magnetic Resonance Imaging (MRI) |
7.4 | Ultrasound |
7.5 | Tomosynthesis |
7.6 | Computed Tomography (CT) |
7.7 | Others |
8.1 | Overview |
8.2 | North America |
8.2.1 | The U.S. |
8.2.2 | Canada |
8.3 | Europe |
8.3.1 | The U.K. |
8.3.2 | Germany |
8.3.3 | France |
8.3.4 | Italy |
8.3.5 | Spain |
8.3.6 | Poland |
8.3.7 | Netherlands |
8.3.8 | Switzerland |
8.3.9 | Austria |
8.3.10 | Rest of Europe |
8.4 | Asia-Pacific |
8.4.1 | Japan |
8.4.2 | China |
8.4.3 | South Korea |
8.4.5 | Australia |
8.4.6 | India |
8.4.7 | Rest of APAC |
8.5 | RoW |
8.5.1 | Brazil |
8.5.2 | Russia |
8.5.3 | Rest of RoW |
9.1 | Cadens Medical Imaging |
9.1.1 | Overview |
9.1.2 | Product Mapping |
9.1.3 | Financials |
9.1.3.1 | Financial Summary |
9.1.4 | SWOT Analysis |
9.2 | EDDA Technology, Inc. |
9.2.1 | Overview |
9.2.2 | Product Mapping |
9.2.3 | Overall Summary |
9.2.3 | SWOT Analysis |
9.3 | Fujifilm Holdings Corporation |
9.3.1 | Overview |
9.3.2 | Product Mapping |
9.3.3 | Financials |
9.3.3.1 | Financial Summary |
9.4 | GE Healthcare |
9.4.1 | Overview |
9.4.2 | Financials |
9.4.2.1 | Financial Summary |
9.4.3 | SWOT Analysis |
9.5 | Hologic Inc. |
9.5.1 | Overview |
9.5.2 | Product Mapping |
9.5.3 | Financials |
9.5.3.1 | Financial Summary |
9.5.4 | SWOT Analysis |
9.6 | iCAD Inc. |
9.6.1 | Overview |
9.6.2 | Product Mapping |
9.6.3 | Financials |
9.6.3.1 | Financial Summary |
9.6.4 | SWOT Analysis |
9.7 | Invivo Corporation |
9.7.1 | Overview |
9.7.2 | Product Mapping |
9.7.2 | SWOT Analysis |
9.8 | Koninklijke Philips N.V. |
9.8.1 | Overview |
9.8.2 | Product Mapping |
9.8.3 | Financials |
9.8.3.1 | Financial Summary |
9.8.4 | SWOT Analysis |
9.9 | Median Technologies |
9.9.1 | Overview |
9.9.2 | Product Mapping |
9.9.3 | Financials |
9.9.3.1 | Financial Summary |
9.9.4 | SWOT Analysis |
9.10 | Merge Healthcare Inc. |
9.10.1 | Overview |
9.10.2 | Product Mapping |
9.10.3 | Financials |
9.10.3.1 | Financial Summary |
9.10.4 | SWOT Analysis |
9.11 | Neusoft Corporation |
9.11.1 | Overview |
9.11.2 | Product Mapping |
9.11.3 | Financials |
9.11.3.1 | Financial Summary |
9.11.4 | SWOT Analysis |
9.12 | Parascript LLC |
9.12.1 | Overview |
9.12.2 | Product Mapping |
9.12.3 | Overall Summary |
9.12.4 | SWOT Analysis |
9.13 | Riverain Technologies |
9.13.1 | Overview |
9.13.2 | Product Mapping |
9.13.3 | Overall Summary |
9.13.4 | SWOT Analysis |
9.14 | Samsung Medison Co. Ltd. |
9.14.1 | Overview |
9.14.2 | Product Mapping |
9.14.3 | Financials |
9.14.3.1 | Financial Summary |
9.14.4 | SWOT Analysis |
9.15 | Siemens Healthineers |
9.15.1 | Overview |
9.15.2 | Product Mapping |
9.15.3 | Overall Summary |
9.15.4 | SWOT Analysis |
9.16 | Agfa Healthcare |
9.16.1 | Overview |
9.17 | McKesson Corporation |
9.17.1 | Overview |
9.18 | Xinapse Systems Ltd |
9.18.1 | Overview |
1 | New Product Launches, Developments and Testing |
2 | Patents, Approvals and Certifications |
3 | Mergers and Acquisitions |
4 | Collaborations, Joint Ventures & Partnerships |
5 | Business Expansions |
6 | Other Strategies |
7 | Technological Trend-Some of the FDA approved CADx |
8 | Supply Chain Analysis |
9 | Patent Landscape |
10 | Consortiums, Associations and Regulatory Bodies |
11 | Some of the Commercialized Mammography CADx Systems |
12 | Some of the CADx System for Lung Cancer |
13 | Some of the CADx System for Colorectal Cancer |
14 | Europe: Key Players |
1 | CADx Drivers & Challenges |
2 | Global CADx Market Share by Application, 2016 |
3 | Global CADx Market Share by Application, 2025 |
4 | Global CADx Application Market Growth Rate (CAGR, 2017-2025) |
5 | CADx Market Share by Imaging Modalities, 2016 |
6 | CADx Market Share by Imaging Modalities, 2025 |
7 | Global CADx Imaging Modalities Market Growth Rate (CAGR, 2017-2025) |
8 | Top Computer Aided Diagnostics Market and Growth Rate (CAGR, 2017-2025) |
9 | Global CADx Market by Countries Growth Rate (CAGR, 2017-2025) |
10 | Global CADx Market Value by Geography, 2016 & 2025 ($Million) |
11 | Global CADx Market Share by Geography, 2016 |
12 | Global CADx Market Share by Geography, 2025 |
13 | Global CADx Market by Geography Growth Rate (CAGR, 2017-2025) |
14 | Global Computer Aided Diagnostics Market Segmentation |
15 | Research Methodology |
16 | Data Triangulation |
17 | Key Data Points From Secondary Sources |
18 | Secondary Data Sources |
19 | Key Data Points From Primary Sources |
20 | Top-Down Approach (Segmental Analysis) |
21 | Bottom-Up Approach (Segmental Analysis) |
22 | Assumptions and Limitations |
23 | Data and Prediction Modelling |
24 | The Four Major Components of CADx Scheme |
25 | CADx System Installation Data |
26 | Market Trend |
27 | CADx Deep Learning Need in Radiology |
28 | Advantages of Computer Aided Diagnostics |
29 | Market Dynamics |
30 | Market Drivers |
31 | Market Challenges |
32 | Market Opportunities |
33 | Recent Market Development Strategy Snapshot Analysis |
34 | Key Market Developments & Strategies |
35 | Global CADx Market by Application |
36 | Global CADx Market by Application, 2016-2025 |
37 | Global CADx Application Market by Type, 2016-2025 |
38 | Global CADx Oncology Application Market 2016-2025 ($Million) |
39 | Global CADx Other Diseases Application Market 2016-2025 ($Million) |
40 | Breast Cancer Application CADx Market, 2016-2025 ($Million) |
41 | Global CADx Lung Cancer Application Market 2016-2025 ($Million) |
42 | Global CADx Prostate Cancer Application Market, 2016-2025 ($Million) |
43 | Global CADx Liver Cancer Application Market, 2016-2025 ($Million) |
44 | Global CADx Other Cancers Application Market, 2016-2025 ($Million) |
45 | Global CADx Other Diseases Application Market 2016-2025 ($Million) |
46 | Neurological Indications |
47 | Global CADx Market by Imaging Modalities |
48 | Global CADx Market by Imaging Modalities, 2016-2025 ($Million) |
49 | MRI & CT Scan Volume data, 2015 |
50 | Global CADx Mammography Market, 2016-2025 ($Million) |
51 | Mammogram Screening Reported, 2014-2015 |
52 | APAC Mammogram Units Reported, 2014 |
53 | U.S. Breast Screening Data |
54 | Global CADx Magnetic Resonance Imaging Market, 2016-2025 ($Million) |
55 | Global CADx Ultrasound Imaging Market, 2016-2025 ($Million) |
56 | Global CADx Tomosynthesis Market, 2016-2025 ($Million) |
57 | Global CADx Computed Tomography (CT) Market, 2016-2025 ($Million) |
58 | Global CADx Other Imaging Modalities Market, 2016-2025 ($Million) |
59 | Common Types of Nuclear Medicine Imaging |
60 | Global Computer Aided Diagnostics Market by Geography |
61 | Global CADx Market by Geography, 2016-2025 ($Million) |
62 | North America CADx Market, 2016-2025 ($Million) |
63 | North America CADx Market by Country, 2016-2025 ($Million) |
64 | U.S. CADx Market Value, 2016-2025 ($Million) |
65 | Canada CADx Market Value, 2016-2025 ($Million) |
66 | Canada: CADx Market Drivers |
67 | Europe CADx Market, 2016-2025 ($Million) |
68 | Europe CADx Market by Country, 2016-2025 ($Million) |
69 | U.K CADx Market, 2016-2025 ($Million) |
70 | Germany CADx Market, 2016-2025 ($Million) |
71 | France CADx Market, 2016-2025 ($Million) |
72 | Italy CADx Market, 2016-2025 ($Million) |
73 | Spain CADx Market, 2016-2025 ($Million) |
74 | Poland CADx Market, 2016-2025 ($Million) |
75 | Netherlands CADx Market, 2016-2025 ($Million) |
76 | Switzerland CADx Market, 2016-2025 ($Million) |
77 | Austria CADx Market, 2016-2025 ($Million) |
78 | Rest of Europe CADx Market, 2016-2025 ($Million) |
79 | Asia-Pacific (APAC) CADx Market, 2016-2025 ($Million) |
80 | APAC CADx Market by Country, 2016-2025 ($Million) |
81 | Japan CADx Market, 2016-2025 ($Million) |
82 | China CADx Market, 2016-2025 ($Million) |
83 | South Korea CADx Market , 2016-2025 ($Million) |
84 | Australia CADx Market, 2016-2025 ($Million) |
85 | India CADx Market, 2016-2025 ($Million) |
86 | Rest of APAC CADx Market, 2016-2025 ($Million) |
87 | RoW CADx Market, 2026-2025 ($Million) |
88 | RoW CADx Market, 2016-2025 ($Million) |
89 | RoW CADx Market by Country, 2016-2025 ($Million) |
90 | Brazil CADx Market, 2016-2025 ($Million) |
91 | Russia CADx Market, 2016-2025 ($Million) |
92 | Rest of RoW CADx Market, 2016-2025 ($Million) |
93 | Cadens Medical Imaging: Product Mapping |
94 | Cadens Medical Imaging: SWOT Analysis |
95 | EDDA Technology, Inc. : Product Mapping |
96 | EDDA Technology, Inc. : SWOT Analysis |
97 | Fujifilm Holdings Corporation : Product Mapping |
98 | Fujifilm Holdings Corporation : Overall Financials (2014-2016) |
99 | Fujifilm Holdings Corporation : Net Revenue by Business Segment (2014-2016) |
100 | Fujifilm Holdings Corporation : Net Revenue by Business Sub-Segment 2016 |
101 | Fujifilm Holdings Corporation : Net Revenue by Region 2016 |
102 | Fujifilm Holdings Corporation : SWOT Analysis |
103 | GE Healthcare : Overall Financials (2014-2016) |
104 | GE Healthcare : Net Revenue by Business Segment (2014-2016) |
105 | GE Healthcare : Net Revenue by Business Sub-Segment (2014-2016) |
106 | GE Healthcare : Net Revenue by Region (2014-2016) |
107 | GE Healthcare: SWOT Analysis |
108 | Hologic Inc.: Product Mapping |
109 | Hologic Inc.: Overall Financials (2014-2016) |
110 | Hologic Inc. : Net Revenue by Business Segment (2014-2016) |
111 | Hologic Inc.: Net Revenue by Region (2014-2016) |
112 | Hologic Inc.: SWOT Analysis |
113 | iCAD Inc. : Product Mapping |
114 | iCAD Inc. : Overall Financials (2014-2016) |
115 | iCAD Inc. : Net Revenue by Business Segment (2014-2016) |
116 | iCAD Inc. : Net Revenue by Business Sub-Segment (2014-2016) |
117 | iCAD Inc. : Net Revenue by Region 2016 |
118 | iCAD Inc. : SWOT Analysis |
119 | Invivo Corporation: Product Mapping |
120 | Invivo Corporation : SWOT Analysis |
121 | Koninklijke Philips N.V.: Product Mapping |
122 | Koninklijke Philips N.V. : Overall Financials (2014-2016) |
123 | Koninklijke Philips N.V. : Net Revenue by Business Segment (2014-2016) |
124 | Koninklijke Philips N.V. : Net Revenue by Business Sub-Segment 2016 |
125 | Koninklijke Philips N.V. : Healthcare Revenue 2015 |
126 | Koninklijke Philips N.V. : SWOT Analysis |
127 | Median Technologies : Product Mapping |
128 | Median Technologies : Overall Financials (2014-2016) |
129 | Median Technologies : Net Revenue by Region (2014-2016) |
130 | Median Technologies: SWOT Analysis |
131 | Merge Healthcare Inc. : Product Mapping |
132 | Merge Healthcare Inc. : Overall Financials (2014-2016) |
133 | Merge Healthcare Inc. : Net Revenue by Business Segment 2016 |
134 | Merge Healthcare Inc.: Net Revenue by Business Segment (2014-2015) |
135 | Merge Healthcare Inc.: Net Revenue by Region (2014-2015) |
136 | Merge Healthcare Inc. : SWOT Analysis |
137 | Neusoft Corporation: Product Mapping |
138 | Neusoft Corporation: Overall Financials (2014-2016) |
139 | Neusoft Corporation: SWOT Analysis |
140 | Parascript LLC: Product Mapping |
141 | Parascript LLC: SWOT Analysis |
142 | Riverain Technologies: Product Mapping |
143 | Riverain Technologies: SWOT Analysis |
144 | Samsung Medison Co. Ltd. : Product Mapping |
145 | Samsung Electronics Co. Ltd.: Overall Financials (2014-2016) |
146 | Samsung Electronics Co. Ltd.: Net Revenue by Business Segment (2014-2016) |
147 | Samsung Electronics Co. Ltd.: Net Revenue by Region (2014-2016) |
148 | Samsung Electronics Co. Ltd.: SWOT Analysis |
149 | Siemens Healthineers: Product Mapping |
150 | Siemens Healthineers : Overall Financials (2014-2016) |
151 | Siemens Healthineers: Net Revenue by Region (2014-2016) |
152 | Siemens Healthineers: Net Revenue by Business Segment (2014-2016) |
153 | Siemens Healthineers: SWOT Analysis |
Report Description
The computer aided diagnostics (CAD) have emerged as one of the major potential tools in the medical imaging and diagnostic radiology. The performance and interpretation of diagnostic radiology test is a complex process, since handling and interpretation of the large volume of medical data and images can lead to increasing chances of interpretation errors by the radiologists. However, the solution to the prevention of these errors is the usage of computer aided diagnostics (CAD), along with several imaging modalities, in order to analyse and interpret medical images more accurately and precisely. The primary factors associated with the usage of CAD solutions are decreased false negative rate, accurate detection of cancer at an early stage, increased specificity and sensitivity of the diagnostics tests, improved intra- and inter-reader variability and reduced mortality rates.
This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.
The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of developments, trends and key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of the competitors within the global computer aided diagnostics (CAD) market.
The report includes the profiles of the major players in the market that allows the readers to get an insight into the various industry trends. Some of the leading companies in the market are iCAD Inc., Hologic Inc., EDDA Technology, Inc., GE Healthcare, Merge Healthcare Inc., Siemens Healthcare, Agfa-Gevaert N.V., Fujifilm Medical Systems, Philips Healthcare, Samsung Medison, Neusoft Corporation, Invivo Corporation, Cadens Medical Imaging, Riverain technologies, Median Technologies and McKesson Corporation.
Key Questions Answered in this Report
The following key questions have been addressed in the report:
- What are the major market drivers, challenges and opportunities of the global computer aided diagnostics market?
- How the global computer aided diagnostics (CAD) market is evolving during the forecast period?
- What are the driving and restraining factors in the global computer aided diagnostics (CAD) market?
- What are the market shares of the leading segments and sub-segments of the global computer aided diagnostics (CAD) market in 2016 and 2025?
- How will each segment of the computer aided diagnostics (CAD) market grow over the forecast period and how much revenue will these account for in 2025?
- How will the market share of the leading companies change in 2017 and which country will lead the market in 2017?
- How will the industry evolve during the forecast period between 2017 and 2025?
- What are the key developmental strategies implemented in different types across all regions?
- Which geographical region will lead the global computer aided diagnostics market by the end of the forecast period?
- What are the market trends and key developments in this market?
Market Overview
With the advent of speech recognition software and computer aided diagnostics (CAD), the replacement of radiologists by computers has been swirling around for years. The introduction of deep learning and machine intelligence has re-ignited this discussion and the industry leaders are discussing what might happen in the upcoming 20 years. Handling and interpretation of large volume of medical data and images can lead to an increasing chances of errors by radiologist. Several tasks in radiology are extremely difficult, such as finding small lesions among several layers of fibro glandular breast tissues. The other tasks can be time consuming such as reviewing a large number of MRI or CT slices. However, the intent of CADx solutions is to aid the radiologists to perform the tasks more effectively and accurately with greater safety and speed.
The computer aided diagnostics (CAD) is a concept established by equally taking into account the roles of physicians and computers. It is based on computer algorithm (deep learning) which serves as “second reader” or “second opinion” in making the final decisions by the radiologists in the analytics and interpretations of huge collection of medical data. This technique of CADx helps the radiologists in accurately interpreting the images and identify the potential findings to avoid incorrect interpretations or overlooking of lesions.
The rising incidence of various types of cancer such as breast, lung, prostate and colorectal, cancer is the primary responsible factor for the growth of CADx market. Furthermore, advancements in digital imaging techniques, improved efficiencies of CADx solutions, ease of integration of CADx solutions with various imaging equipment and growing awareness among the patients about early detection of cancer, have boosted the overall growth of this market. Moreover, the expansion of CADx applications to newer clinical areas, active research and development activities in medical imaging, rapid transition of hospitals to promote automatic workflow integration in their current work environment and rising installation base of CADx solutions in various multispecialty hospitals, is further expected to accentuate the growth of this market in the near future. However, certain restraining factors such as lack of adequate clinical data for validating the clinical efficacy of CADx solutions in its role of early diagnosis of the disease, disinclination of healthcare professionals in accepting these solutions as a standard imaging tool and premium pricing, might hamper the growth of this market.
This research study includes an extensive analysis of the global computer aided diagnostics (CAD) market, by application, diagnostics modalities and geographical regions, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed on the basis of their current and future market size, considering the macro and micro environmental factors.
The global computer aided diagnostics market is forecast to reach $XX million by 2025. The CADx market broadly focuses on major application areas (oncology, cardiovascular, and neurological) and various imaging modalities (mammography, MRI, tomosynthesis, etc.). The application segment of this market comprise of oncology and other diseases (neurological, cardiovascular and musculoskeletal) application areas. The oncology segment is further sub-segmented into breast, lung, colorectal, prostate, liver and other cancer. The breast cancer acquired the highest market value of $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, prostate cancer is growing at the highest CAGR XX%. The reason for such a strong market share is attributed to the rising incidence of breast cancer. According to the World Cancer Research Fund International, breast cancer is the most common cancer in women worldwide, with nearly 1.7 million new cases diagnosed in 2012. Further, according to National Cancer Institute, it is estimated that there will be 252,710 new cases of female breast cancer and an estimated XX people will die of this disease in 2017.
The Imaging modalities segment of this market comprise of various imaging tools such as mammography, magnetic resonance imaging (MRI), ultrasound imaging, tomosynthesis, computed tomography (CT) and others. The mammography acquired the highest market value of $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, the tomosynthesis imaging modalities is growing at the highest CAGR of XX%. The reason for holding such a strong market share is attributed to the continuous advancement in various digital imaging techniques, especially in mammography, MRI, tomosynthesis and computed tomography (CT).
The computer aided diagnostics market’s geographical segment comprise of North America (the U.S. and Canada), Europe (Germany, France, Italy, Spain, Poland, Netherlands, Switzerland, and Austria among others), Asia-Pacific (Japan, China, South Korea, Australia, and India among others) and RoW (Brazil, Russia and Middle East among others). In the computer aided diagnostics market’s segment, North America dominated the market with the highest market value $XX million in 2016, growing at a CAGR of XX% and is anticipated to reach $XX million in 2025. However, the Asia-Pacific region is expected to grow at a highest CAGR of XX%.
The key players in the global computer aided diagnostics (CAD) market are Hologic Corporation, GE Healthcare, Invivo Corporation, ICADx Inc., Cadens Imaging, Siemens Healthcare, EDDA Technology and Agfa-Gevaert group. The market players are getting into the strategies such as collaborations, partnership & joint ventures, business expansion & contracts, product launches & developments, patents approvals & certifications, and mergers & acquisitions among others. The growing research and development, investments to integrate CADx with 3D imaging, rising demand for automated image analysis techniques and growing impact of cloud based solutions, are predicted to emerge as the potential growth drivers for the computer aided diagnostics market in the near future.
Global Computer Aided Diagnostics (CADx) Market - Analysis and Forecast (2017-2025)
(Focus on Application, Imaging Modalities, Country Analysis, Patent Landscape, Market Share Analysis and Competitive Landscape)